VEGFA/VEGFR2-targeted therapies prevent the VEGFA-induced proliferation of regulatory T cells in cancer

  • Terme M
  • Tartour E
  • Taieb J
  • 21


    Mendeley users who have this article in their library.
  • 15


    Citations of this article.


Some of the anti-angiogenic agents currently used to treat solid malignancies have effects on tumor endothelial cells as well as on immune cells. We have recently demonstrated that targeting the vascular endothelial growth factor A (VEGFA)/VEGF receptor 2 (VEGFR2) signaling pathway reduces the proportion of regulatory T cells (Treg) in a mouse model of colorectal cancer (CRC) and in metastatic CRC patients as it inhibits tumor-induced Treg proliferation.

Author-supplied keywords

  • Colorectal cancer
  • Immunosuppression
  • Proliferation
  • Regulatory t cells
  • Tumor
  • Vegf-a

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


  • Magali Terme

  • Eric Tartour

  • Julien Taieb

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free